Use of Ketamine Infusions for Treatment of Complex Regional Pain Syndrome: A Systematic Review.
chronic pain
complex regional pain syndrome (crps)
infusion
ketamine
pain syndrome
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
accepted:
19
10
2021
entrez:
25
11
2021
pubmed:
26
11
2021
medline:
26
11
2021
Statut:
epublish
Résumé
This systematic review aims to review clinical studies on the use of ketamine infusion for patients with treatment-resistant complex regional pain syndrome (CRPS). The following systematic review was registered on the International Prospective Register of Systematic Reviews (PROSPERO) (CRD42021228470). Studies for the systematic review were identified through three databases: PubMed, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and Cochrane Reviews. Inclusion criteria for studies consisted of randomized clinical trials or cohort studies that conducted trials on the use of ketamine infusion for pain relief in patients with CRPS. Exclusion criteria for studies included any studies that were systematic reviews, meta-analyses, case reports, literature reviews, or animal studies. In the included studies, the primary outcome of interest was the post-drug administration pain score. In this systematic review, 14 studies met the inclusion criteria and were reviewed. In these studies, the dosage of ketamine infusion used ranged from 0.15 mg/kg to 7 mg/kg with the primary indication being the treatment of CRPS. In 13 of the studies, ketamine infusion resulted in a decrease in pain scores and relief of symptoms. Patients who received ketamine infusion for treatment-resistant CRPS self-reported adequate pain relief with treatment. This suggests that ketamine infusion may be a useful form of treatment for patients with no significant pain relief with other conservative measures. Future large-scale studies, including randomized double-blind placebo-controlled trials on the use of ketamine infusion for CRPS, must be conducted in a large-scale population to further assess the effectiveness of ketamine infusion in these populations.
Identifiants
pubmed: 34820225
doi: 10.7759/cureus.18910
pmc: PMC8601938
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e18910Informations de copyright
Copyright © 2021, Chitneni et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pain. 2009 Dec 15;147(1-3):107-15
pubmed: 19783371
Pain Med. 2008 Jan-Feb;9(1):44-54
pubmed: 18254766
Arch Clin Neuropsychol. 2007 Aug;22(6):719-29
pubmed: 17611073
Handb Exp Pharmacol. 2008;(182):313-33
pubmed: 18175098
Pain Physician. 2017 Feb;20(2):E257-E268
pubmed: 28158163
BMC Pediatr. 2015 Dec 01;15:198
pubmed: 26620833
Depress Anxiety. 2016 Aug;33(8):689-97
pubmed: 27062302
Adv Psychosom Med. 2011;30:139-161
pubmed: 21508630
Eur J Pain. 2011 Mar;15(3):258-67
pubmed: 20638877
Anesthesiology. 1997 Apr;86(4):903-17
pubmed: 9105235
Pain Med. 2004 Sep;5(3):263-75
pubmed: 15367304
Pain Med. 2008 Nov;9(8):1173-201
pubmed: 18266808
Reg Anesth Pain Med. 2018 Jul;43(5):521-546
pubmed: 29870458
Pain. 2009 Oct;145(3):304-311
pubmed: 19604642
Br J Anaesth. 2015 Jul;115(1):146-7
pubmed: 26089467
Br J Psychiatry. 2006 Aug;189:173-9
pubmed: 16880489
Handchir Mikrochir Plast Chir. 2016 Jun;48(3):143-7
pubmed: 27311072
Pain Physician. 2010 Jul-Aug;13(4):379-87
pubmed: 20648207
Eur J Pain. 2010 Mar;14(3):302-7
pubmed: 19540140
Addiction. 2012 Jan;107(1):27-38
pubmed: 21777321
Br J Anaesth. 2013 Jun;110(6):1010-6
pubmed: 23384733
Pain Med. 2012 Feb;13(2):263-9
pubmed: 21939497
J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):160-7
pubmed: 27275042
Clin J Pain. 2020 Jul;36(7):516-523
pubmed: 32243301
Mediterr J Rheumatol. 2019 Mar 28;30(1):16-25
pubmed: 32185338
Neuromodulation. 2018 Jul;21(5):423-430
pubmed: 28961359